[ad_1]
Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in the aftermath of the selloff.
[ad_2]
Source link
These Eli Lilly executives have been scooping up stock after its big drop
